Pancreatic Cancer Research

ResearcherAzienda Ospedaliera di Desio e VimercateActive in the last 2 years

Stefano Granieri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9167-3400; OpenAlex author ID A5078947557. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 4

  1. Impact of R0/R1 Margin Status on Overall Survival in Node-Positive Resected Pancreatic Ductal Adenocarcinoma: Meta-Analysis. First author DOI 10.1245/s10434-026-19850-4↗
  2. ASO Author Reflections: R0 Resection Should Not Be Dismissed in Node-Positive Pancreatic Ductal Adenocarcinoma. First author DOI 10.1245/s10434-026-20047-y↗
  3. The Role of Non-Peripancreatic Lymph Nodes in the Survival of Patients Suffering from Pancreatic Cancer of the Body and Tail: A Systematic Review and Meta-Anal… Co-author DOI 10.3390/cancers15082322↗
  4. Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: A systematic review and meta-analysis. Co-author DOI 10.1016/j.ejso.2022.05.030↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alessandro Michele Bonomi · 3 shared papers, 2023–2026 · strength 0.82
  2. Marc G. Besselink · 2 shared papers, 2026 · strength 0.63
  3. Simone Frassini · 2 shared papers, 2022–2023 · strength 0.35
  4. Christian Cotsoglou · 1 shared paper, 2023 · strength 0.18
  5. Lorenzo Cobianchi · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.